Health exchange and prevention of HIV: The evidence for effectiveness is beyond dispute [1]

Addiction

Volumn 102, Issue 1, 2007, Pages 161-162

  Wodak, Alex ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COUNSELING; ECOLOGY; EPIDEMIC; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LETTER; RISK REDUCTION; SEROPREVALENCE; WORLD HEALTH ORGANIZATION;

HIV INFECTIONS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; PROGRAM EVALUATION;

EID: 33845760020     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01708.x     Document Type: Letter

References (18)

1. Amundsen E. J. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users. Addiction 2006; 101: 911-12.
2. Hurley S. F., Jolley D. J., Kaldor J. M. Effectiveness of needle exchange programmes for prevention of HIV infection. Lancet 1997; 349: 1797-800.
3. MacDonald M., Law M., Kaldor J., Hales J., Dore G. D. Effectiveness of needle and syringe programmes for preventing HIV transmission. Int J Drug Policy 2003; 14: 353-7.
4. Health Outcomes International. Return of Investment in Needle and Syringe Programs in Australia. Canberra: Commonwealth Department of Health and Aging; 2002.
5. Wodak A., Cooney A. Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users. Geneva: World Health Organization; 2004.
6. Bradford Hill A. The environment and disease: association or causation. Proc Roy Soc Med 1965; 58: 295-300;
7. Proc Roy Soc Med 1998;179 (3 Suppl.): S43-50.
8. General Accounting Office. Needle Exchange Programs: Research Suggests Promise as an AIDS Prevention Strategy. Washington, DC: Government Printing Office; 1993.
9. National Commission on AIDS. The Twin Epidemics of Substance Use and HIV. Washington, DC: 1991.
10. Lurie P., Reingold A. L., editors. The Public Health Impact of Needle Exchange Programs in the United States and Abroad, vol. 1. Atlanta, GA: Centers for Disease Control and Prevention; 1993.
11. Office of Technology Assessment of the US Congress. The Effectiveness of AIDS Prevention Efforts. Washington, DC: US Government Printing Office; 1995.
12. National Institutes of Health Consensus Panel. Interventions to Prevent HIV Risk Behaviours. Bethesda, MD: National Institutes Health; 1997.
13. Satcher D. (Surgeon General). Evidence-Based Findings on the Efficacy of Syringe Exchange Programs: an Analysis of the Scientific Research Completed Since April 1998. Washington, DC: United States Department of Health & Human Sciences; 2000.
14. Institute of Medicine of the National Academy of Science. No Time to Lose: Getting More from HIV Prevention. Washington, DC: National Academies Press; 2001.
15. Metzger D. S., Navaline H. HIV prevention among injecting drug users: the need for integrated models. J Urban Health 2003; 80: 59-66.
16. Beardsell S., Coyle a. a review of research on the nature and quality of HIV testing services: a proposal for process based studies. Soc Sci Med 1996; 42: 733-43.
17. Elwy a. R., Hart G. J., Hawkes S., Petticrew M. Effectiveness of interventions to prevent sexually transmitted infections and human immunodeficiency virus in heterosexual men: a systematic review. Arch Intern Med 2002; 162: 1818-30.
18. Ljungberg B., Christensson B., Tunving K., Andersson B., Landvall B., Lundberg M. et al. HIV prevention among injecting drug users: three years of experience from a syringe exchange program in Sweden. J Acq Immune Defic Syndr 1991; 4: 890-5.